Sino Biopharmaceutical Ltd - Liabilities and Stockholders Equity

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Liabilities-and-Stockholders-Equity" stands at 74.89 Billion Hong Kong Dollars as of 06/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Liabilities and Stockholders Equity" stands at 74.89 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 20.61 percent compared to the value the year prior.
The 1 year change in percent is 20.61.
The 3 year change in percent is 15.34.
The 5 year change in percent is 28.33.
The 10 year change in percent is 456.21.

The Serie's long term average value is 35.11 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 113.31 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2011, to it's latest available value, on 06/30/2025, is +1,417.38%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 06/30/2025, is 0.0%.